The KCNK3 Knockout KYSE-30 Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal population derived from the KYSE-30 human esophageal squamous cell carcinoma line. This mixed pool carries heterogeneous KCNK3 disruptions, generating a loss-of-function model for TASK-1 potassium channels. The polyclonal format avoids clonal selection, preserving genetic diversity and better mimicking tumor heterogeneity for functional studies.
KYSE-30 is an adherent, epithelial-like cell line established from a moderately differentiated human esophageal squamous cell carcinoma. It retains aggressive cancer phenotypes, including rapid proliferation and invasive capacity, and serves as a standard model for esophageal cancer research. Its human origin and squamous lineage provide a physiologically relevant system to investigate molecular drivers of esophageal malignancy and drug responsiveness.
KCNK3 encodes TASK-1, a pH- and hypoxia-sensitive two-pore domain potassium channel that regulates resting membrane potential. Its activity is modulated by extracellular acidosis, Gq/11-coupled receptors, and protein kinase C. Downstream, TASK-1 influences voltage-gated calcium channels, calcium signaling, and the MAPK/ERK pathway, thereby impacting apoptotic proteins (Bcl-2) and cyclin D1. Interacting factors include TASK-3, 14-3-3 proteins, and ??-arrestins. Disruption is predicted to depolarize membrane potential, altering calcium dynamics and MAPK signaling. Key pathway mediators are phospholipase C, ERK1/2, and HIF-1??.
In KYSE-30 esophageal cancer cells, KCNK3 knockout provides a tool to examine potassium channel roles in the tumor microenvironment. Esophageal tumors often encounter acidic and hypoxic conditions where TASK-1 acts as a pH sensor. Loss-of-function may perturb adaptation to these stresses, affecting survival and invasiveness. The polyclonal population captures phenotypic diversity, enabling robust assessment of TASK-1-dependent effects on cancer cell viability, apoptosis, and migration.
Researchers can employ electrophysiological patch clamp recordings to measure altered membrane potentials, western blotting and RT-qPCR to validate KCNK3 disruption, and functional assays such as MTT, Annexin V apoptosis detection, pH sensitivity tests, and transwell migration/invasion assays. Transcriptomic profiling via RNA-seq can identify gene expression changes upon knockout. The pool is suitable for screening TASK-1 modulators in esophageal carcinoma. For further details, contact Ascent Research.
